Advertisement
Australia markets closed

  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     

  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     

  • AUD/USD

    0.6418
    -0.0008 (-0.12%)
     

  • OIL

    82.15
    -0.58 (-0.70%)
     

  • GOLD

    2,391.90
    -6.10 (-0.25%)
     

  • Bitcoin AUD

    101,861.17
    +4,524.57 (+4.65%)
     

  • CMC Crypto 200

    1,334.09
    +21.46 (+1.66%)
     

  • AUD/EUR

    0.6019
    -0.0012 (-0.20%)
     

  • AUD/NZD

    1.0892
    +0.0017 (+0.16%)
     

  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     

  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     

  • FTSE

    7,835.11
    -41.94 (-0.53%)
     

  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     

  • DAX

    17,719.27
    -118.13 (-0.66%)
     

  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

Asia Pacific Starch Softgel Capsules Industry to 2027 - by Application, Distribution Channel and Country

Research and Markets
·5-min read

Dublin, Sept. 21, 2020 (GLOBE NEWSWIRE) -- The "Asia Pacific Starch Softgel Capsules Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Application (Pharmaceutical, Health Supplements, Others); Distribution Channel (Supermarket and Hypermarket, Pharmacy and Drugstore, Online Provider); and Country" report has been added to ResearchAndMarkets.com's offering.

The Asia Pacific starch softgel capsule market is expected to reach US$ 122.54 million by 2027 from US$ 82.55 million in 2019. The market is estimated to grow at a CAGR of 5.2% from 2020 to 2027.

Factors such as advantages of softgel capsules and rise in preference for vegetarian capsules in Asian countries is expected to boost the market growth over the years. Moreover, developing healthcare industry in Asia Pacific is likely to create growth opportunities for the market during the forecast period.

The healthcare industry in Asia Pacific is witnessing rapid transformations since the past few years. Countries across the world have preferred advanced solutions that are simple and effective in healthcare sector. With a need for better healthcare facilities, technology-enabled care (TEC) solutions are being preferred in the healthcare systems in the emerging economies. As per the India Brand Equity Foundation, the Indian pharmaceutical sector is expected to grow to US$ 100 billion, and the medical device market is expected to grow US$ 25 billion by 2025. Pharmaceuticals export from India stood at US$ 20.70 billion in 2020. In 2019, India's domestic pharmaceutical market turnover reached Rs 1.4 lakh crore (US$ 20.03 billion), up by 9.8% y-o-y from Rs 129,015 crore (US$ 18.12 billion) in 2018.

Similarly, as per the authorized government portal site of China - China.org.cn, China's pharmaceutical market has been constantly growing in recent years, and is estimated to reach US$161.8 billion by 2023, taking a 30% share of the global pharmaceutical market.

Thus, growing healthcare industry in countries in Asia Pacific is likely to fuel the starch softgel capsules market in the region.

Based on application, the Asia Pacific starch softgel capsules market is segmented into pharmaceutical, health supplements, and others. In 2019, the health supplements segment held the largest share of the market. The segment is expected to grow at the fastest rate during the forecast period. In terms of distribution channel, the Asia Pacific starch softgel capsules market is categorized into supermarket and hypermarket, pharmacy and drugstore, and online provider. The pharmacy and drugstore segment held the highest share of the starch softgel capsules market in 2019. However, the online provider segment is anticipated to witness growth at a significant rate during the forecast period.

A few major secondary sources for Asia Pacific starch softgel capsules market included in the report are Centers for Disease Control and Prevention, World Heart Foundation, Global Nutrition Report, India Brand Equity Foundation, The Korean Diabetes Association, China.org.cn (China Government Portal), among others.

Key Topics Covered:

1. Introduction

2. Asia Pacific Starch Softgel Capsule Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Starch Softgel Capsule Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific Starch Softgel Capsule Market - Asia Pacific PEST Analysis
4.3 Expert Opinion

5. Asia Pacific Starch Softgel Capsule Market Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Advantages of Softgel Capsules
5.1.2 Rise in Preference for Vegetarian Capsules in Asian Countries
5.2 Key Restraints
5.2.1 Difficulties in Optimizing Cellulose/Starch for API Delivery
5.3 Key Market Opportunities
5.3.1 Developing Healthcare Industry in Asia Pacific Region
5.4 Future Trend
5.4.1 Rising Trend of Online Distribution in Asia Pacific Region
5.5 Impact Analysis

6. Starch Softgel Capsule Market - Asia Pacific Analysis
6.1 Asia Pacific Starch Softgel Capsule Market Revenue Forecasts and Analysis

7. Starch Softgel Capsules Market Analysis- by Application
7.1 Overview
7.2 Starch Softgel Capsules Market Share, By Application, 2019 & 2027 (%)
7.3 Pharmaceutical
7.3.1 Overview
7.3.2 Pharmaceutical Market Revenue and Forecasts to 2027 (US$ Million)
7.4 Health Supplements
7.4.1 Overview
7.4.2 Health Supplements Market Revenue and Forecasts to 2027 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others Market Revenue and Forecasts to 2027 (US$ Million)

8. Starch Softgel Capsules Market Analysis- by Distribution Channel
8.1 Overview
8.2 Starch Softgel Capsules Market Share, By Distribution Channel, 2019 & 2027 (%)
8.3 Supermarket and Hypermarket
8.3.1 Overview
8.3.2 Supermarket and Hypermarket Market Revenue and Forecasts to 2027 (US$ Million)
8.4 Pharmacy and Drugstore
8.4.1 Overview
8.4.2 Pharmacy and Drugstore Market Revenue and Forecasts to 2027 (US$ Million)
8.5 Online Providers
8.5.1 Overview
8.5.2 Online Providers Market Revenue and Forecasts to 2027 (US$ Million)

9. Starch Softgel Capsule Market Revenue and Forecasts To 2027 - Country Analysis

10. Impact of COVID-19 Pandemic on Asia Pacific Starch Softgel Capsule Market
10.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic

11. Company Profiles
11.1 Hunan Er-Kang Pharmaceutical Co., Ltd
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Softcaps
11.3 Fuji Capsule Co., Ltd.
11.4 Aenova Holding GmbH
11.5 Sirio Pharma Co., Ltd.

12. Appendix
12.1 About the Publisher
12.2 Glossary of Terms

For more information about this report visit https://www.researchandmarkets.com/r/afikab

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

ADVERTISEMENT
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900